Details for New Drug Application (NDA): 005929
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
NDA 005929 describes D.H.E. 45, which is a drug marketed by Bausch and is included in one NDA. Additional details are available on the D.H.E. 45 profile page.
The generic ingredient in D.H.E. 45 is dihydroergotamine mesylate. There are six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
The generic ingredient in D.H.E. 45 is dihydroergotamine mesylate. There are six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
Summary for 005929
| Tradename: | D.H.E. 45 |
| Applicant: | Bausch |
| Ingredient: | dihydroergotamine mesylate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 005929
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
